Burn Care Market

The burn care market is projected to reach USD 3.35 billion by 2030 from USD 2.55 billion in 2025, at a CAGR of 5.6% during this period. Several key factors contribute to this market growth. There is an increasing incidence of burn injuries worldwide, particularly in low- and middle-income countries where occupational injuries, household accidents, and insufficient safety measures are common. To meet the growing clinical demand, various technological advancements have been introduced, including advanced burn dressings, biologics, and burn wound therapy devices, all of which significantly enhance treatment effectiveness. Additionally, there is a rising awareness among healthcare professionals about the importance of early and specialized burn care, leading to an increased demand for advanced burn care products.

Some of the major players in the global burn care market include Smith+Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), and ConvaTec Group Plc (UK). These companies have adopted a variety of growth strategies, both organic and inorganic, such as acquisitions, product launches, partnerships, agreements, and expansions. These strategies have enabled them to strengthen their international presence and capture a larger share of the burn care market. By implementing these approaches, the market players have successfully expanded their offerings across different geographies.

To know about the assumptions considered for the study download the pdf brochure

Smith+Nephew is distinguished by its advanced wound care solutions and robust research and development capabilities, enabling it to provide effective burn care products. Mölnlycke Health Care AB has solidified its market position through strategic partnerships. Cardinal Health Inc. utilizes its extensive distribution network and diverse product line to reach a wide range of healthcare facilities, thereby increasing its share in the burn care market. Integra LifeSciences Holdings Corporation is recognized for its broad range of biologics that offer crucial support for severe burns. ConvaTec Group Plc has strengthened its market presence through global expansion and strategic acquisitions.

In July 2024, Mölnlycke Health Care AB (Sweden) and MediWound Ltd. (Israel) entered into an agreement to strengthen their partnership. As part of this agreement, Mölnlycke has invested in MediWound, a global leader in next-generation enzymatic therapeutics for non-surgical wound debridement. This investment will support Mölnlycke’s mission in wound care, helping to alleviate the burden of wounds for patients.

Mölnlycke Health Care AB also boasts a comprehensive product portfolio in the advanced wound care market. The company's leading position in this sector is largely due to its robust global sales and distribution network, which allows it to effectively market its products in various countries. Mölnlycke primarily utilizes inorganic strategies, such as partnerships, to maintain its market position. For example, in May 2024, the company formed a new partnership with the Phoenix Society, a burn survivor organization in the US. Through this collaboration, Mölnlycke will support the Phoenix Society's initiatives with its extensive range of burn care solutions.

In March 2024, Integra LifeSciences Holdings Corporation launched MicroMatrix Flex in the US. MicroMatrix Flex is designed for managing wounds, including partial-thickness and full-thickness burns.

Smith+Nephew offers a comprehensive range of advanced burn care products, including advanced burn dressings, traditional burn care items, burn wound therapy devices, and biologics. The company enjoys a strong global market presence, largely due to its exceptional distribution network. Its worldwide reach and the critical nature of its products significantly enhance access to healthcare in both developed and emerging economies.

Smith+Nephew has also intensified its focus on research & development (R&D) to create unique and improved products. The company invested USD 289.0 million, USD 339.0 million, and USD 345.0 million in R&D activities in 2024, 2023, and 2022, respectively. These substantial investments in innovative product development have established Smith+Nephew as a prominent player in the burn care market.

Market Ranking

The burn care market is highly consolidated. Smith+Nephew (UK) stands out due to its advanced wound care solutions and robust research and development capabilities, allowing the company to offer effective burn care products. In contrast, Mölnlycke Health Care AB (Sweden) enhances its market position through strategic partnerships. Cardinal Health Inc. (US) leverages its extensive distribution network and diverse product line to reach a broad range of healthcare facilities, thereby increasing its share of the burn care market. Integra LifeSciences Holdings Corporation (US) provides a wide array of biologic products tailored for critical burns. Additionally, ConvaTec Group Plc (UK) has fortified its market position through global outreach and strategic acquisitions. Competition in this market is driven by product innovation and the rising demands of regulatory compliance.

Related Reports:

Burn Care Market by Product (Advanced (Collagen, Film, Hydrogel, Foam, Alginate Dressings), Therapy Devices (Debridement, NPWT), Biologics, Traditional), Burn Degree (First, Second, Third-degree Burns), End User (Hospitals, ASCs) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com